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Purpose: To investigate the effects of different time-resolved angiography with stochastic trajectories
(TWIST) k-space undersampling schemes on calculated pharmacokinetic dynamic contrast-enhanced
(DCE) vascular parameters.
Methods: A digital perfusion phantom was employed to simulate effects of TWIST on characteristics
of signal changes in DCE. Furthermore, DCE-MRI was acquired without undersampling in a group
of patients with head and neck squamous cell carcinoma and used to simulate a range of TWIST
schemes. Errors were calculated as differences between reference and TWIST-simulated DCE param-
eters. Parametrical error maps were used to display the averaged results from all tumors.
Results: For a relatively wide range of undersampling schemes, errors in pharmacokinetic parameters
due to TWIST were under 10% for the volume transfer constant, K trans, and total extracellular
extravascular space volume, Ve. TWIST induced errors in the total blood plasma volume, Vp, were
the largest observed, and these were inversely dependent on the area of the fully sampled k-space.
The magnitudes of errors were not correlated with K trans, Vp and weakly correlated with Ve.
Conclusions: The authors demonstrated methods to validate and optimize k-space view-sharing
techniques for pharmacokinetic DCE studies using a range of clinically relevant spatial and tem-
poral patient derived data. The authors found a range of undersampling patterns for which the
TWIST sequence can be reliably used in pharmacokinetic DCE-MRI. The parameter maps created
in the study can help to make a decision between temporal and spatial resolution demands and
the quality of enhancement curve characterization. C 2016 Author(s). All article content, except
where otherwise noted, is licensed under a Creative Commons Attribution 3.0 Unported License.
[http://dx.doi.org/10.1118/1.4964795]
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1. INTRODUCTION
View-sharing techniques allow for significant reduction of
acquisition time, enabling fast high-resolution measurements
without compromising anatomical coverage. Such techniques
are often used in cardiac function examinations,1,2 angi-
ography,3 flow and perfusion imaging,4–7 and situations
where breath-holds are required.8,9 View-sharing methods
employ partial k-space updating with assumptions of a priori
knowledge to recover spatial resolution10–13 or coverage
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loss.14 Usually, it is possible to vary the density of sampling in
order to match acquisition parameters with clinical temporal
and spatial redundancy (e.g., respiratory or cardiac motion
and vascular input function), and thus, reduce errors. In the
case of time-resolved angiography with stochastic trajectories
(TWIST),11 it is possible to vary the size of the central
(fully sampled) and peripheral parts of k-space, together with
the percentage of periphery sampled at a given acquisition
time-point. In the case of 4D acquisition, the use of a
small central compartment results in increased temporal
resolution. This is especially beneficial for dynamic contrast-
enhanced (DCE) MRI, where a high temporal resolution is
required to appropriately characterize a progressive signal
intensity change after injecting gadolinium-based (Gd-based)
intravenous contrast.15 Typical temporal resolution in these
types of measurements is between 2 and 10 s depending
on the level of perfusion, kinetic model used, and the
necessity of motion compensation (i.e., breath holding or
cardiac triggering). Variable flip angle 4D gradient echo
sequences are commonly used in DCE-MRI to calculate
longitudinal relaxation time, T1, using a signal ratio between
the proton density (low flip angle) and T1-weighted (higher
flip angle) images. T1 relaxation time changes allow for Gd
concentration calculations as a function of time.16 The series
ofT1-weighted images is usually acquired for a period of 3–10
min, allowing the characterization of uptake and washout of
the contrast agent in studied tissues. Using appropriate kinetic
models, the dynamics of Gd concentration can be related
to vascular parameters such as the volume transfer constant
between blood plasma and extracellular extravascular space
(K trans), the total extracellular extravascular space volume
(Ve), or the total blood plasma volume (Vp). View-sharing
techniques can be compatible with these methods. However,
undersampling of peripheral parts of k-space may lead to
impaired characterization of enhancement curves, ringing
artifacts, and impaired fat suppression.17–19
In this study, we investigate the effects of different k-
space undersampling schemes with TWIST on calculated
pharmacokinetic (PK) DCE vascular parameters. High tem-
poral resolution DCE data from a group of patients with head
and neck squamous cell carcinoma (HNSCC) were used to
evaluate TWIST-induced errors in K trans, Ve, and Vp.
2. METHODS
MR images acquired prior to treatment in eight patients
with HNSCC were used in the study. Written informed consent
was obtained from all patients in this study, which was
approved by the institutional review board (Royal Marsden
Hospital Committee for Clinical Research) and research ethics
committee (NHS REC number 10/H0801/32).
2.A. MRI protocol
DCE data acquired with a high temporal resolution without
the use of TWIST were used as the ground truth reference.
MRI was performed at 1.5 T (Philips Intera, Philips Medical
Systems, Best, Netherlands). Patients were imaged in a 5-point
thermoplastic mask and two flexible surface coils centered
over the volume of interest were used. The DCE protocol
included a trans-axial 3D spoiled fast gradient echo sequence
(TE = 1 ms, TR = 4 ms, FOV = 256× 256 mm2, acquisi-
tion/reconstruction matrix: 112× 128/128× 128, 10 slices,
with 2×2×5 mm3 voxels, parallel imaging factor of 1.7, and
partial Fourier acquisition of 60% in the anterior–posterior
direction). A series of 20 proton density-weighted images
(flip angle, FA = 4◦) was initially acquired prior to contrast
injection. This was followed by 100 T1-weighted acquisitions
(FA= 20◦) obtained sequentially with 1.5 s temporal resolu-
tion. Gd contrast was injected intravenously at the start of the
tenth dynamic scan as bolus through a peripherally placed
cannula using an automatic injector (0.2 ml/kg body mass,
3 ml/s injection rate, Dotarem, Guerbet, France) and followed
by a saline flush (20 ml at 3 ml/s).
2.B. PK modeling
Regions of interest (ROIs) were manually delineated by a
radiation oncologist together with an expert MRI radiologist
on T1-weighted images at the time-point with maximum
contrast concentration (e.g., 11th dynamic measurement,
approximately 15 s after the start of contrast injection) for
each slice, around all primary tumors and involved lymph
nodes. Signal ratio between the proton density (FA = 4◦)
and T1-weighted (FA= 20◦) images was used to calculate T1
relaxation time. First five images in each dynamic acquisition
were excluded from analysis to ensure magnetization equi-
librium. Signal from remaining 15 proton-weighted images
acquired before the contrast injection was averaged in order
to reduce the potential influence of incidental motion (i.e., due
to swallowing). Changes of T1 were used for Gd concentration
calculations as a function of time, used in the PK modeling.
The gadolinium contrast onset (∼10th dynamic) time was
manually adjusted for each DCE session. The data were
analyzed using the software package MRIW (Institute of
Cancer Research, UK)20 with the extended Kety model21
and a population-based arterial input function (AIF).22 A
set of parameters was derived including: K trans, Ve, and Vp.
DCE maps were produced for each parameter and lesion
ROI.
2.C. Numerical DCE phantom
A digital perfusion phantom23 was employed to simulate
effects of TWIST undersampling on characteristics of signal
changes in DCE-MRI using  (Mathworks, Cambridge
MA). The extended Kety model was used to generate
enhancement curves for K trans in a range of 0.125–0.7 min−1
(fixed Ve = 0.25, Vp = 0.01), Ve in a range of 0.125–0.7
(K trans = 0.25, Vp = 0.01), Vp in a range of 0.03–0.2 (K trans
= 0.25, Ve = 0.25), and temporal resolution of 0.5 s. Simulated
homogenous lesions (radius= 3 pixels) were positioned along
the phantom perimeter and a set of 300 simulated images
(128×128 pixels) was generated.
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F. 1. TWIST acquisition scheme for A= 50% and B = 33% (P—phase encoding, F—frequency encoding, and S—partition/slice direction): k-space was
divided into central (A1) and 3 peripheral parts (B1–3). In the first acquisition (t1), the full k-space [A1(t1), B1(t1), B2(t1), B3(t1)] was sampled. In the next
acquisition, only the central A1(t2) and 33% of peripheral B1(t2) parts of the k-space were sampled and the missing data of B2–3(t2) copied from adjacent time
point t1: B2–3(t2)= B2–3(t1). Similarly, in the following acquisition steps, all points in compartment A and a percentage of the points in compartment B were
sampled, with missing portions of B copied from adjacent time points.
2.D. TWIST simulations
A set of images measured or generated at each DCE time-
point was Fourier transformed to obtain k-space data using
. Each k-space data set was divided into central and
peripheral parts (Fig. 1). Five different areas of the central
part (A= 2%, 10%, 20%, 33%, and 50%) were considered.
The peripheral part was subsequently undersampled, such that
a defined percentage of remaining k-space points (B = 10%,
33%, and 50%) was randomly sampled. For each image, all
points in compartment A and a percentage of the points in
compartment B were used, with missing portions of B copied
from adjacent time points.
Created k-spaces were Fourier transformed to obtain a set
of simulated TWIST images used for DCE pharmacokinetic
calculations (Fig. 2). This approach is similar to that used
F. 2. Schematic diagram of TWIST simulation: fully sampled magnitude image sets were Fourier transformed to obtain k-space data. Five different sizes
of the central part (A= 2%, 10%, 20%, 33%, and 50%) were considered. The compartment A was fully sampled while B was sampled with reduced density
(B = 10%, 33%, and 50%) with missing portions of B copied from preceding time points. Simulated k-spaces were Fourier transformed to obtain a set of
TWIST images used for DCE calculations.
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by Song et al. in a simulated renography phantom study.17
Ratios of TWIST undersampled and fully sampled reference
acquisition times (TATW) were calculated for different TWIST
combinations.
2.E. Error calculation for DCE parameters
In order to determine the magnitude of K trans, Ve, and
Vp errors, sets of DCE TWIST images were simulated for
the digital phantom and every patient, with various TWIST
parameter combinations. Absolute errors were calculated
as a difference between measured fully sampled reference
(DCEref) and TWIST-simulated (DCETWIST) DCE parameters
on a pixel-by-pixel basis,
DCEerror(x,y)= |DCETWIST(x,y)−DCEref(x,y)| , (1)
where x and y are given pixel coordinates. The percentage
errors were than calculated as follows:
DCE%error(x,y)= DCE(x,y)errorDCE(x,y)ref ∗100%. (2)
The median percentage difference was calculated for all
voxels within each patient ROI (n = 8) and for 15 simulated
A/B combinations (A = 2%, 10%, 20%, 33%, 50% and
B = 10%, 33%, 50%). In the case of the phantom simulations,
12 TWIST combinations (A = 10%, 20%, 33%, 50% and
B = 20%, 33%, 50%) were used and the results were presented
in Table I. In the next step, the TWIST error distribution was
studied for the whole group of patients. The results obtained
for patient ROIs were averaged for each undersampling pattern
and the results also presented in the form of parametrical
TWIST error maps. Standard deviations (SDs) of the TWIST
parameter errors were calculated and also reported in the
form of parametrical maps, allowing for the assessment of
intrapatient variability of parameter errors.
Kendall’s tau (τ)24 was used to test for correlations between
K trans, Ve, Vp, and corresponding percentage errors for all
voxels. The null hypothesis stated that there was no correlation
between measured DCE parameters and percentage errors.
The strength of correlation was tested24 and was considered
significant if p < 0.01. Statistical analysis was performed
using the  Statistics Toolbox.
3. RESULTS
3.A. Phantom simulations
The effect of TWIST on DCE parametrical maps simulated
for A,B = 20%,20% is presented in Fig. 3. Relatively high k-
space undersampling results in blurring and ringing artifacts.
DCE TWIST error maps are presented in Table I. The
error magnitudes depended on the choice of undersampling
pattern, parameter type, and its value. The highest errors were
observed for Vp (max error 30%) and the smallest for K trans,
with errors below 15% for all measured values. There was a
pronounced increase of error for A< 33%, whereby the error
increased with the value of the DCE parameter.
T I. Numerical DCE phantom: TWIST errors (%) measured for various
A,B combinations and DCE parameter ranges: K trans: 0.125–0.7 min−1
(fixed Ve = 0.25, Vp = 0.01), Ve: 0.125–0.7 (K trans= 0.25, Vp = 0.01), and
Vp: 0.03–0.2 (K trans= 0.25, Ve = 0.25).
K trans
A,B (%) 0.125 0.25 0.4 0.55 0.7
50,50 5 1 1 1 2
50,33 5 1 3 1 1
50,20 5 1 2 1 2
33,50 4 1 2 1 1
33,33 5 1 3 1 1
33,20 4 7 9 9 8
20,50 3 9 11 17 19
20,33 6 5 5 7 5
20,20 5 5 5 8 4
10,50 2 1 1 4 7
10,33 2 2 4 4 4
10,20 2 1 2 3 6
Ve
0.125 0.25 0.4 0.55 0.7
50,50 1 1 2 1 1
50,33 0 0 1 3 1
50,20 1 0 2 2 1
33,50 0 0 2 1 1
33,33 16 9 8 4 5
33,20 1 1 1 2 3
20,50 4 8 10 8 12
20,33 3 5 7 5 8
20,20 4 5 5 5 7
10,50 3 3 8 1 6
10,33 3 3 5 1 4
10,20 3 2 5 1 5
Vp
0.03 0.06 0.1 0.15 0.2
50,50 3 1 2 1 2
50,33 4 3 1 1 4
50,20 4 1 1 1 3
33,50 3 3 1 1 3
33,33 4 2 1 1 3
33,20 8 13 20 25 29
20,50 3 4 11 8 29
20,33 1 2 6 6 5
20,20 2 1 8 5 6
10,50 1 1 5 3 1
10,33 3 1 3 3 2
10,20 1 1 4 3 1
3.B. Clinical simulations
Patient characteristics and tumor stages are summarized
in Table II. The results for TWIST DCE parameter errors are
presented in Table III. For all lesion ROIs and patients without
the use of TWIST, the median values of the parameters K trans,
Ve, and Vp were 0.194 (SD= 0.09) min−1, 0.223 (SD= 0.12),
and 0.022 (SD = 0.012), respectively. DCE errors depended
on the choice of undersampling pattern and varied between
parameter types.
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F. 3. Numerical DCE phantom: K trans, Ve, and Vp maps calculated for a fully sampled (top) and TWIST A,B = 20%,20% undersampled data. Simulated
homogenous lesions with varying K trans, Ve, and Vp were positioned along the phantom perimeter.
Median TWIST percentage error maps (HNSCC patients)
are presented in Fig. 4. The K trans and Ve differences were
under 10% for a relatively wide range of undersampling
schemes: A> 30% and B > 20%. TWIST had the largest effect
on the Vp parameter, where differences lower than 15% were
only achieved using less extensive view-sharing parameters
of A> 35% with an extended region between B: 25–35 and
A> 25%.
Intrapatient variability of the K trans error was greater for
small A and B with error standard deviation >5% for TWIST
parameters A and B < 25%. Standard deviations of total
extracellular extravascular space volume errors were generally
higher (max SD= 10%) than K trans for all TWIST schemes.
T II. Summary of patient characteristic. N/A = not available.
Patient Age Sex TNM Primary site HPV status
1 56 M T2N2cM0 Oropharynx Positive
2 43 M T1N2cM0 Nasopharynx N/A
3 62 M T4N2bM0 Oropharynx N/A
4 59 M T3N2bM0 Oropharynx Positive
5 51 M T1N2bM0 Hypopharynx Negative
6 52 M T2N2bM0 Oropharynx Positive
7 63 F T3N2bM0 Oropharynx Negative
8 62 M T3N1M0 Hypopharynx Negative
The variability of plasma volume errors was higher for small
B values with a steep increase at B < 20%.
There was no significant correlation (median τ = −0.12,
p = 0.09) observed between the K trans values calculated for
all measured voxels and corresponding TWIST percentage
errors for all undersampling regimes used. Similarly, there
was no correlation for Vp (median τ = 0.09, p= 0.11) and a
weak, statistically significant, negative correlation (median τ
=−0.16, p< 0.001) for Ve parameters and measured percent-
age errors. There was also no correlation between tumor ROI
size and TWIST percentage errors (K trans τ = 0.35, p= 0.28;
Ve: τ =−0.29, p= 0.4, Vp: τ = 0.14, p= 0.55).
4. DISCUSSION
The high temporal resolution of the conventional 3D
gradient echo sequence allows for reliable calculations of DCE
parameters. However, short acquisition times are achieved at
a cost of decreased spatial resolution or volume coverage,
which can lead to significant partial volume effects. This can
be problematic in the case of longitudinal DCE measurements
during a course of treatment, where decreasing tumor volume
in responding lesions may cause the number of viable tumor
voxels to become limited. Limited superior/inferior lesion
coverage can also be troublesome in HNSCC where local
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T III. TWIST DCE parameter errors, ROI sizes, and acquisition time ratios (TATW) for all patients and undersampling combinations.
A,B (%) 50,50 50,33 50,10 33,50 33,33 33,10 20,50 20,33 20,10 10,50 10,33 10,10 02,50 02,33 02,10
TATW 0.75 0.67 0.55 0.67 0.55 0.40 0.60 0.46 0.28 0.55 0.40 0.19 0.51 0.34 0.12
Pt No. ROI (pixels) Error (%): K trans
1 57 2.3 1.6 1.3 4.4 5.7 6.6 5.0 6.4 10.3 4.8 5.1 14.1 6.9 4.1 29.9
2 46 6.7 4.8 4.9 5.8 4.8 3.6 5.5 4.8 4.2 5.4 4.7 6.4 5.2 4.7 4.9
3 197 8.5 9.6 9.6 8.1 9.5 14.7 8.3 9.7 15.5 9.0 10.1 13.7 10.3 11.1 5.6
4 118 2.7 2.7 2.6 4.4 4.3 3.6 5.3 5.5 3.8 6.0 6.8 3.7 7.9 5.1 4.3
5 54 6.6 6.3 5.3 6.9 8.0 6.1 6.7 9.2 7.3 6.3 10.4 9.2 5.9 7.5 6.6
6 334 8.2 8.5 1.8 8.3 11.4 6.5 9.5 13.6 10.8 11.6 15.9 16.2 16.3 17.6 19.0
7 288 8.0 8.0 2.2 5.4 7.2 6.4 4.8 9.7 8.6 8.3 9.1 13.0 10.0 6.5 5.0
8 96 2.9 4.3 4.7 6.6 8.9 6.8 3.8 8.8 9.4 5.0 8.4 5.5 6.5 7.7 8.0
Mean 149 5.7 5.7 4.1 6.2 7.5 6.8 6.1 8.5 8.7 7.1 8.8 10.2 8.6 8.0 10.4
SD 112 2.7 2.8 2.7 1.5 2.5 3.5 1.9 2.8 3.8 2.4 3.6 4.7 3.6 4.5 9.2
Pt No. (Pixels) Error (%): Ve
1 57 4.6 4.8 5.6 6.7 4.7 6.8 6.0 4.1 9.6 3.2 3.0 14.2 4.7 3.4 19.3
2 46 19.2 20.6 20.8 27.1 17.5 22.3 27.6 14.6 18.1 23.1 11.1 8.5 14.1 10.5 11.3
3 197 4.6 3.7 3.3 3.2 3.5 14.8 3.5 4.0 15.4 5.1 5.1 8.7 8.1 8.5 7.3
4 118 2.0 2.0 1.9 3.2 2.5 3.0 3.6 2.8 3.3 3.7 3.1 3.0 4.0 3.2 3.3
5 54 7.6 15.8 15.0 17.3 10.7 12.9 8.2 10.6 13.6 8.9 5.1 11.1 11.0 8.0 14.6
6 334 13.5 11.7 14.7 7.1 11.2 19.6 7.3 9.2 19.6 17.2 8.4 7.9 15.0 8.1 10.5
7 288 4.5 5.2 4.2 7.6 5.6 8.6 3.5 5.4 12.5 5.7 8.5 7.3 5.4 4.4 7.8
8 96 4.9 4.6 3.2 9.5 6.6 10.1 7.3 6.8 11.2 6.1 7.7 8.8 8.6 6.4 10.1
Mean 149 7.6 8.5 8.6 10.2 7.8 12.3 8.4 7.2 12.9 9.1 6.5 8.7 8.9 6.6 10.5
SD 112 5.8 6.7 7.1 8.1 5.0 6.5 8.0 4.0 5.1 7.2 2.9 3.2 4.2 2.7 4.9
Pt No. (Pixels) Error (%): Vp
1 57 9.2 7.8 8.4 15.1 9.7 9.0 21.6 13.4 11.8 30.6 19.6 16.9 43.9 29.0 36.8
2 46 8.2 6.5 4.9 22.4 10.7 8.8 26.5 12.6 9.5 25.0 13.6 8.1 23.2 14.9 9.9
3 197 12.1 8.8 5.9 17.6 13.9 20.0 22.5 17.9 23.9 28.5 22.4 22.2 41.3 29.6 18.1
4 118 8.9 8.3 1.8 19.3 11.8 21.6 16.5 13.1 26.2 4.0 13.3 19.4 20.0 8.1 25.9
5 8.9 8.9 7.0 4.5 18.5 12.1 8.5 25.8 12.3 8.0 26.9 18.0 10.7 33.6 21.3 23.4
6 9.0 9.0 8.8 6.2 18.8 11.0 12.6 22.9 15.9 20.1 29.0 17.4 14.1 33.5 21.6 15.8
7 7.2 7.2 7.8 7.5 19.5 16.7 21.9 19.0 14.3 27.6 14.6 17.0 22.2 30.3 20.0 22.9
8 7.3 7.3 8.8 7.6 19.2 9.4 15.3 20.4 13.8 15.0 16.3 15.3 16.3 27.3 18.6 23.8
Mean 149 8.9 8.0 5.8 18.8 11.9 14.7 21.9 14.2 17.8 21.9 17.1 16.2 31.6 20.4 22.1
SD 112 1.5 0.9 2.1 2.0 2.4 5.8 3.3 1.9 7.7 9.3 3.1 5.1 8.3 7.0 7.9
lymph nodes are a common site of metastatic disease and
should be imaged together with the primary site. In the case of
HNSCC, the desirable superior/inferior coverage is between
10 and 20 cm with a 20–25 cm in-plane field of view, allowing
for full head and neck anatomy coverage.
There is increasing interest in the use of functional imaging
for biological target volume delineation in radiotherapy
treatment planning.25,26 Identification of less well-perfused
regions of the tumor is of interest, as these may reflect
hypoxic subvolumes, and therefore, areas of relative radiore-
sistance.27,28 However, this requires not only in-plane but also
through-plane high spatial resolution in order to accurately
identify and delineate biological tumor subvolumes, which
could be potentially used for a local dose boosting. Confidence
in the coregistration of radiotherapy dosimetric data and
DCE parameters is particularly important where steep dose
gradients exist between target volumes and surrounding
healthy tissue. This could be further improved, thanks to
the recent development of MR-based RT planning29 and
development of MR-Linac.30
The use of TWIST can overcome these limitations of
conventional 3D gradient-echo techniques by increasing the
user’s ability to find a good compromise between coverage,
temporal, and spatial resolution.
We demonstrated the influence of the TWIST view-sharing
technique on DCE calculations using a digital phantom and
heterogeneous groups of primary and nodal tumor sites. The
use of simulated phantom data enabled the generation of
reference DCE data not influenced by a limited temporal
resolution and for a wide range of vascular parameters
(K trans, Ve, and Vp). We found that the plasma volume was
the most significantly affected parameter by the TWIST
undersampling, which can be explained by a dependence ofVp
on the initial Gd uptake peak. K trans and Ve parameter errors
were below 10% for a wide range of TWIST combinations
and K trans and Ve values, as presented in Table I. The data
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F. 4. TWIST parameter error maps–clinical results. An absolute value of mean percentage difference of K trans, Ve, and Vp calculated using reference (no
TWIST) and simulated TWIST DCE image sets is shown on the left. The white iso-contours indicate areas of all K trans,Ve, andVp errors below 15%. Standard
deviations for the percentage differences are shown on the right. Simulated TWIST undersampling partition sizes: A= 2%, 10%, 20%, 33%, 50% and B = 10%,
33%, 50%).
suggest that it is possible to achieve errors below 15% in all
K trans, Ve, and Vp parameters for A> 20% and Vp below 0.1,
which is expected in HNSCC (median Vp = 0.022±0.012 in
this study).
Error maps created for various undersampling schemes can
help to assist in the choice of TWIST parameters to be applied
for DCE studies. For example, it would be possible to improve
the spatial resolution of the DCE experimental protocol used
in this study from 2×2×5 mm3 to 2×2×2.75 mm3 employing
A,B = 33%,33% TWIST undersampling, maintaining high
temporal resolution (1.5 s) and coverage. In this case, the
predicted TWIST induced errors would be below 10% for
K trans, Ve and under 15% for the Vp. The resulting spatial
resolution is in line with routine radiotherapy treatment plans
Medical Physics, Vol. 43, No. 11, November 2016
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taking into consideration patient positioning, motion-related
uncertainties, and deliverable treatment beam geometry.31
The potential detrimental effects of view-sharing methods
on MRI image quality were recognized before. Most studies
however focused on qualitative assessment of clinical im-
ages17–19 with few performing a quantitative analysis of dy-
namic signal errors.32,33 The majority of these studies em-
ployed the “keyhole” method, which is an extreme case of
view-sharing, where only the centre of k-space is updated
continually, while the periphery of k-space is acquired only
once at the beginning, and optionally again at the end of the dy-
namic series.12 This leads to a strong geometrical dependence
of dynamic signal errors and the requirement for the central k-
space size to be restricted by the approximate minimum size
of the expected lesion.32 The TWIST method is less sensitive
to these effects due to a sparse but continuous acquisition of
peripheral part of the k-space. In our study, we do not observe
correlation between lesion size and DCE TWIST errors.
One of the requirements of DCE-MRI is a requirement
for a reliable measure of the AIF, representing a time
course of the contrast concentration in the blood plasma
pool. Patient-specific measurement of the AIF from a vessel
feeding the tumor would be desirable. In practice, however, a
population-based AIF is commonly used for measuring cohort
and individual vascular parameters since the patient-specific
repeatability is hampered by in-flow effects, nonlinear signal
response, nonuniform B1 field, pulsatile flow, and partial
volume effects.34 This approach was also adapted in this
study. However, it is expected that higher temporal resolution
achieved with TWIST could be beneficial in characterization
of patient-specific AIF. Song et al.17 found A,B = 20%,20%
TWIST sampling optimal in characterization of simulated
normal and diseased kidney function (glomerular filtration
rate and renal plasma flow errors <10%) with one aortic input
function.
Our work has several limitations. First, the k-space is
obtained by Fourier transforming magnitude images, and as
a consequence, phase effects on the signal are disregarded.
This simulation applies either to situations where field
inhomogeneity is negligible or to situations where the central
portion of the k-space is sufficiently sampled to map field
inhomogeneity. In a real TWIST-DCE experiment, the 3D
k-space is sparsely sampled in the phase and compartment
(slice) directions (Fig. 1). In our work, data are effectively
undersampled in phase and readout direction and therefore
is an equivalent of sagittal or coronal rather than axial 3D
acquisition. Another limitation is the fact that the sampling
frequency of the simulated data was constant and determined
by the acquired reference DCE data. This therefore represents
the use of TWIST to increase spatial resolution or coverage.
This is not the case if the TWIST is used to improve temporal
resolution where the sampling frequency would be higher
and the induced DCE errors are likely to be lower than
presented in our study. Finally, our limited patient cohort size
does not represent full range of possible vascular and spatial
tumor characteristics and our clinical evaluation is specific to
HNSCC tumors. This was addressed to a certain extent using
the digital phantom, which enabled to study TWIST effects
for a wide range of DCE parameters and without temporal
resolution limitations. In our work, we combined a DCE
phantom with the well-known geometry (Shepp-Logan)23
and Qualitative Imaging Biomarkers Alliance (QIBA).35
However, a disadvantage of this approach is an arbitrary
geometry of simulated enhancing lesions, the lack of spatial
heterogeneity, and fixed size of regions of interest. As a
consequence, the TWIST error magnitude can be elevated
for particular undersampling patterns, for which effects of
spatial blurring and compromised edge encoding populate
significant subvolumes of simulated ROIs. This could explain
higher errors calculated with A = 20%, when compared to
A = 10%. The main advantage of using clinical data from
Head & Neck studies is to reproduce accurately the range of
spatial frequencies present in the region of interest, and thus
evaluate more accurately the error introduced into pharma-
cokinetic parameters by the use of view sharing techniques.
It also allows for an appropriate level of physiological noise
influencing the quality of pharmacokinetic modeling. Despite
of these shortcomings, our simulation achieves its objectives,
as it eliminates an appropriate amount of information in space
and time leading to distortion caused by TWIST to the PK
parameters in HNSCC mapped. In our clinical simulations,
we did not observe correlations between K trans, Ve, Vp values,
and the magnitude of error, for a heterogeneous group of
tumor ROIs. This is in line with the phantom simulations
showing pronounced increase of error for DCE parameters
higher than those observed in the studied HNSCC patient
group. Furthermore our simulations provide an evaluation
of the minimum sampling requirements to keep the error
level on the determination of pharmacokinetic parameters
K trans, Ve, and Vp under a given threshold. In the case of
HNSCC tumors (median K trans= 0.194 min−1, Ve = 0.223, and
Vp = 0.022 in this study), the recommended size of the TWIST
undersampling is A and B > 20%. This allows achieving errors
below 15% in all DCE parameters.
5. CONCLUSION
In conclusion, we demonstrated a method to validate
and optimize k-space view-sharing techniques used for
pharmacokinetic DCE studies in head and neck cancers. In
this setting, the TWIST sequence can be used reliably for
pharmacokinetic DCE-MRI using a range of under-sampling
patterns. The parameter maps created in the study can be used
to balance temporal and spatial resolution demands to allow
optimal enhancement curve characterization.
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